Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate

J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):880-2. doi: 10.2459/JCM.0000000000000160.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Cardiac Tamponade / chemically induced
  • Cardiac Tamponade / microbiology
  • Electrocardiography
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Methotrexate / adverse effects*
  • Pericardial Effusion / chemically induced
  • Pericardial Effusion / microbiology
  • Pericarditis / chemically induced*
  • Pericarditis / diagnosis
  • Pericarditis / drug therapy
  • Pericarditis / immunology
  • Pericarditis / microbiology
  • Rituximab
  • Staphylococcal Infections / chemically induced*
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / immunology
  • Staphylococcal Infections / microbiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Rituximab
  • Methotrexate